- A New Frontier for Convergence in Gastroenterology and Hepatology
Nov. 30(Sat) 07:30-08:30 |
Meet the Professor | Flamingo (Main 2F) |
Chair(s) | Sung Kwan Shin (Korea) | |
07:30-08:30 | Endoscopic management for obesity | Roman Turro Arau (Spain) |
Nov. 30(Sat) 07:30-08:30 |
Meet the professor | Skylark (Main 2F) |
Chair(s) | Jin Lee (Korea), Jin-Hyeok Hwang (Korea) | |
07:30-08:30 | Bile acids and cancer | David Q.H. Wang (USA) |
Nov. 30(Sat) 07:30-08:30 |
Breakfast Symposium (SYSMEX KOREA) | Convention Hall C (4F) |
Chair(s) | Do Young Kim (Korea) | |
07:30-08:30 | Current status and perspective of a new fibrosis marker, M2BPGi in Japan | Keisuke Hino (Japan) |
Nov. 30(Sat) |
Global unsolved issues in Viral hepatitis | Convention Hall C (4F) |
Chair(s) | Kwang-Hyub Han (Korea), Myung-Ken Lee (Korea), Markus Peck (Austria) | |
08:30-09:00 | Current situation and strategic plan of Hepatitis B in Africa | Djoudalbaye Benjamin (Ethiopia) |
09:00-09:20 | Development of international program for Hepatitis B management | Hoon Sang Lee (Korea) |
09:20-09:40 | Economic Burden and Cost effective Control of Viral hepatitis | Yock Young Dan (Singapore) |
09:40-10:00 | Global strategy to prevent viral hepatitis; focusing on introducing Hepatitis B birth dose in low- and middle-income countries | Daniel Rhee (Korea) |
10:00-10:20 | Role of IASL to strengthen global partnership | Kwang-Hyub Han (Korea) |
10:20-10:30 | Discussion |
Nov. 30(Sat) |
Inter-disciplinary approach in IBD | Convention Hall A (4F) |
Chair(s) | Won Ho Kim (Korea), Suk-Hwan Lee (Korea) | |
09:00-09:22 | Perianal Crohn’s disease: Stem cell therapy or anti-TNFs? | Yong Sik Yun (Korea) |
09:22-09:44 | What surgeons need to know: updates of biologics and small molecules | Kang-Moon Lee (Korea) |
Nov. 30(Sat) |
Management of a visible high-grade dysplasia in a patient with ulcerative pancolitis | Convention Hall A (4F) |
Chair(s) | Won Ho Kim (Korea), Suk-Hwan Lee (Korea) | |
09:45-10:07 | Total proctocolectomy should be first | Hee Cheol Kim (Korea) |
10:07-10:29 | Endoscopic resection should be first | Dong-Hoon Yang (Korea) |
Nov. 30(Sat) 09:00-10:30 |
Video Session (KSG-UGI) | Convention Hall B (4F) |
Chair(s) | Ping-Hong Zhou (China), Vu Van Khien (Vietnam), Gwang Ha Kim (Korea) | |
09:00-09:18 | Magnifying endoscopy with NBI in the stomach, especially for EGC | Gwang Ha Kim (Korea) |
09:18-09:36 | Active GI bleeding: How to treat | Hanglak Lee (Korea) |
09:36-09:54 | ESD with traction method | Hyunsoo Chung (Korea) |
09:54-10:12 | POEM, the submucosal endoscopy: Tips and know-how to be an expert | Do Hoon Kim (Korea) |
10:12-10:30 | Endoscopic management of esophageal fistula and anastomotic leak | Hyuk Soon Choi (Korea) |
Nov. 30(Sat) 09:00-10:30 |
Tips to become a good journal | Emerald Hall A (3F) |
Chair(s) | Young S. Kim (USA), Sang Woo Lee (Korea) | |
09:00-09:30 | Publication ethics | Dong Soo Han (Korea) |
09:30-10:00 | Past and new decade of Gut and Liver | Jong Pil Im (Korea) |
10:00-10:30 | Strategy to be an SCI journal: Clinical and Molecular Hepatology | Yoon Jun Kim (Korea) |
Nov. 30(Sat) 09:00-10:30 |
Obsetiy and metabolic syndrome: Where are we now and where are we going ?: pathophysiology, epidemiology, diagnosis, classification etc. | Emerald Hall B (3F) |
Chair(s) | David Q.H. Wang (USA), Hyun Wook Baik (Korea), Joo-Ho Lee (Korea) | |
09:00-09:22 | Pathophsiology of metabolic syndrome: The cutting edge | David Q.H. Wang (USA) |
09:22-09:44 | Gut microbiome and metabolic syndrome | Myung-Shik Lee (Korea) |
09:44-10:06 | Recent Issues in diagnosis and classification | Yang-hyun Kim (Korea) |
10:06-10:28 | Metabolic syndrome in children and adolescents | Ki Soo Kang (Korea) |
Nov. 30(Sat) 09:00-10:30 |
Which treatment in locally advanced cancers | Diamond Hall (3F) |
Chair(s) | Jin Tae Jung (Korea), Young-Woo Kim (Korea) | |
09:00-09:22 | Locally advanced Esophageal Cancer; Pro CCRT versus Pro Surgery | Young Sin Cho (Korea) |
09:22-09:44 | Locally advanced Esophageal Cancer; Pro CCRT versus Pro Surgery | Jin-Jo Kim (Korea) |
09:44-10:06 | Locally advanced Gastric cancer; neadjuvant versus adjuvant therapy | Hee Seok Moon (Korea) |
10:06-10:28 | Locally advanced Gastric cancer; neadjuvant versus adjuvant therapy | Beom Su Kim (Korea) |
Nov. 30(Sat) |
Grand Ballroom A (Main 2F) | |
Chair(s) | In Kyung Sung (Korea), Kee Wook Jung (Korea) | |
09:00-9:10 | Oesophageal motility disorders in systemic sclerosis: Observational study | sara Ghani (Morocco) |
09:10-9:20 | Long-term results of surgical treatment of GERD in combination with a hiatal hernia | Saidrakhim Lukmonov (Uzbekistan) |
09:20-9:30 | Classification of functional dyspepsia using resting-state functional brain network: a machine learning study | Tao Yin (China) |
09:30-9:40 | Predictors of Decreased Stool Frequency in Constipated Elderly: A Hierarchical Linear Regression Model Approach | Khairil Khuzaini Zulkifli (Malaysia) |
Nov. 30(Sat) |
Grand Ballroom A (Main 2F) | |
Chair(s) | Sang Kil Lee (Korea), Jung-Ho Park (Korea) | |
09:40-9:50 | 99mTc-Phytate is a Suitable Cheaper Alternative to the Gold-standard 99mTc-Sulfur Colloid in Gastric Emptying Scintigraphy: A Validation Study Among Healthy Volunteers | Tengku Ahmad Iskandar Tengku Alang (Malaysia) |
09:50-10:00 | The assessment of high-resolution oesophageal manometry with non obstructive dysphagia | sara Ghani (Morocco) |
10:00-10:10 | Result of colonic Lactobacillus of relativity healthy adults and correlate the link between dairy consumption | Amarjargal Batdelger (Mongolia) |
Nov. 30(Sat) |
Nursing session (KASID) | Flamingo (Main 2F) |
Chair(s) | Jin-Oh Kim (Korea), Young-Seok Cho (Korea) | |
09:00-09:22 | Perioperative pharmacological considerations in IBD | Shin Ju Oh (Korea) |
09:22-09:44 | Complementary and alternative medicine for IBD | Eun ae Kang (Korea) |
09:44-10:06 | Opportunistic infections in IBD: Case-based discussion | Sang Hyoung Park (Korea) |
10:06-10:28 | Adult vaccination recommendations focused in IBD | Won-Suk Choi (Korea) |
Nov. 30(Sat) 11:00-12:30 |
Korean GI Frontiers | Convention Hall A (4F) |
Chair(s) | Won Ho Kim (Korea), Jong Sun Rew (Korea) | |
11:00-11:22 | Transarterial chemoembolization plus external beam radiotherapy vs. sorafenib in HCC | Young-Suk Lim (Korea) |
11:22-11:44 | Helicobacter pylori eradication for the prevention of metachronous gastric cancer | Il Ju Choi (Korea) |
11:44-12:06 | Efficacy and safety of biosimilar CT-P13 compared with originator infliximab in Crohn's disease | Youngho Kim (Korea) |
12:06-12:28 | Observation time in esophagogastroduodenoscopy | Jae Myung Park (Korea) |
Nov. 30(Sat) 11:00-12:30 |
Video Session (KSG-LGI) | Convention Hall B (4F) |
Chair(s) | Han-Mo Chiu (Taiwan), Bo-In Lee (Korea) | |
11:00-11:22 | Diagnosis and differential diagnosis of colorectal polyps: Up-to-date imaging technique | Han-Mo Chiu (Taiwan) |
11:22-11:44 | Surveillance for dysplasia in IBD: chromoendoscopy and image-enhanced endoscopy | Sung Noh Hong (Korea) |
11:44-12:06 | Cold method for colon polpectomy; Why, When, and How? | Bong Min Ko (Korea) |
12:06-12:28 | Tips for complete and safe colorectal ESD for difficult cases | Bo-In Lee (Korea) |
Nov. 30(Sat) |
Special lectures / Opening ceremony | Convention Hall C (4F) |
Chair(s) | Kwang-Hyub Han (Korea) | |
11:00-11:15 | Opening ceremony | |
11:15-11:30 | Long journey of IASL | Samuel Lee (Canana) |
Nov. 30(Sat) |
Professional platform: How to Start and Build-up Academic Career - I | Convention Hall C (4F) |
Chair(s) | Samuel Lee (Canana), Jacob George (Australia) | |
11:30-11:50 | How to conduct a good research | Henry LY Chan (Hong Kong) |
11:50-12:10 | How to write a good paper | Samuel Lee (Canana) |
12:10-12:30 | How to handle big data | Young-Suk Lim (Korea) |
Nov. 30(Sat) 11:00-12:30 |
Go to the deep inside of GI disease | Emerald Hall A (3F) |
Chair(s) | Tae Il Kim (Korea), Thomas Roberts (USA) | |
11:00-11:22 | Recent update of physiology research of GI sensation and motility | Jae Hak Kim (Korea) |
11:22-11:44 | The future of PI3K directed therapies in cancer treatment | Thomas Roberts (USA) |
11:44-12:06 | Recent update of brain-gut-microbiome axis | Geom Seog Seo (Korea) |
12:06-12:28 | Recent update of pathophysiology and therapeutic target of IBD | Seongjoon Ko (Korea) |
Nov. 30(Sat) 11:00-12:30 |
Obestiy and metabolic syndrome: What are the links with GI diseases? | Emerald Hall B (3F) |
Chair(s) | Seung-Jae Myung (Korea), Joo Hyun Sohn (Korea) | |
11:00-11:22 | NAFLD | Seung Up Kim (Korea) |
11:22-11:44 | Obesity and functional gastrointestinal disorders | Ju Yup Lee (Korea) |
11:44-12:06 | Obestiy and metabolic syndrome: What are the links with GI diseases? | Byung Chang Kim (Korea) |
12:06-12:28 | Pancreatobiliary diseases | Dong Hee Koh (Korea) |
Nov. 30(Sat) |
Presidential Lecture | Diamond Hall (3F) |
Chair(s) | Seokho Dong (Korea) | |
11:00-11:40 | Biology of cholangiocytes: from bench to bedside | Ho Soon Choi (Korea) |
Nov. 30(Sat) |
Special Lecture | Diamond Hall (3F) |
Chair(s) | Ho Soon Choi (Korea) | |
11:40-12:20 | Targeting genome dynamics in pancreatic cancer | Volker Ellenrieder (Germany) |
Nov. 30(Sat) 11:00-12:30 |
Grand Ballroom A (Main 2F) | |
Chair(s) | Tae Nyeun Kim (Korea), Dong Wan Seo (Korea) | |
11:00-11:10 | Comparison of Liquid-based Cytology with Conventional Smear Cytology for Endoscopic Ultrasound-guided Fine Needle Aspiration of Solid Pancreatic Masses: Prospective Randomized Non-inferiority Study | Jung Won Chun (Korea) |
11:10-11:20 | Direct peroral cholangioscopy using a new multibending ultra-slim endoscope without device or scope assistance: a large single center experience | Yun Nah Lee (Korea) |
11:20-11:30 | Efficacy of endobiliary radiofrequency ablation plus stenting versus stenting alone in patients with inoperable hilar cholangiocarcinoma | Yun Nah Lee (Korea) |
11:30-11:40 | Innovation of EUS-guided Transmural Gallbladder Drainage using a Novel Self-Expending Metal Stent | Gunn Huh (Korea) |
11:40-11:50 | EUS-guided antegrade metal stent deployment for benign hepaticojejunostomy anastomosis stricture | Atsushi Okuda (Japan) |
11:50-12:00 | Pure NOTES retrograde cholecystectomy using a single channel flexible endoscope: a pilot experiment in a porcine model | Saif Ullah (China) |
Topic forum | Jaihwan Kim (Korea) |
Nov. 30(Sat) |
E-poster Oral (KSGC1) | Flamingo (Main 2F) |
Chair(s) | Dong-Uk Kim (Korea), Eun Sun Kim (Korea) | |
11:00-11:08 | Response after preoperative long course chemoradiotherapy in locally advanced rectal cancer | May Thin Hlaing (Myanmar) |
11:08-11:16 | The Feasibility and Clinical Outcomes of Endoscopic Full Thickness Resection Assisted Laparoscopic Surgery for Duodenal Neuroendocrine Neoplasms | Sunah Suk (Korea) |
11:16-11:24 | comparison of short-term and lond-term results in the treatment of patients with malignant colorectal obstruction:emergency resection or stenting or transanal decompression tube. | Aleksandr Vodoleev (Russian Federation) |
11:24-11:32 | Qurecetin loaded Nano-Lipidic Carriers exerts Diethylnitrosamine induced Hepatic Cancer via attenuation ofcellular inflammation and cell proliferation | Vikas Kumar (India) |
11:32-11:40 | An alternative approach to Radiological image guided Endoscopic Ultrasound- Guided Liver Lesion Biopsy (EUS LLB) with atypical malignancies. | Muhammad Manzoor Ul Haq (Pakistan) |
Nov. 30(Sat) |
Flamingo (Main 2F) | |
Chair(s) | Seonghwan Kim (Korea), Jeong Youp Park (Korea) | |
11:40-11:48 | Clinical Profile of Patients with Hepatocellular Carcinoma at St. Lukes Medical Center and Cardinal Santos Medical Center from 2003-2018 | John Alfredo Raphael Perez Pangilinan (Philippines) |
11:48-11:56 | Just the Tip of the Iceberg: A Case Report on Two Patients Presenting with Sister Mary Josephs Nodule | Carlos Paolo Francisco (Philippines) |
11:56-12:04 | Mucinous Colorectal Cancer Presenting as Pseudomyxoma Peritonei: A Case report | Clarissa Cruz (Philippines) |
12:04-12:12 | A 62-years-old Female with Pancreatic Adenocarcinoma Presenting as Ischemic Enteritis | Carlos Paolo Francisco (Philippines) |
Nov. 30(Sat) 11:00-12:30 |
For the best care of pancreaticobiliary cancers | Skylark (Main 2F) |
Chair(s) | Jun Kyu Lee (Korea), Hee Hyuk Im (Korea) | |
11:00-11:22 | Understanding pancretobiliary cancer | Dongwook Oh (Korea) |
11:22-11:44 | Endoscopic treatment of malignant biliary obstruction | Se Woo Park (Korea) |
11:44-12:06 | Nurse’s role of pancreatobiliary cancers | Mi Soon Kim (Korea) |
12:06-12:28 | Nutrition managements for pancreaticobiliary cancers | MinKyong Yoo (Korea) |
Nov. 30(Sat) |
Controversial issues in liver diseases | Convention Hall C (4F) |
Chair(s) | Kwan Soo Byun (Korea), Han Chu Lee (Korea) | |
13:30-13:50 | NASH Trials: How Far Have We Come? | Jacob George (Australia) |
13:50-14:10 | Non-invasive assessment in cirrhosis or advanced fibrosis | Young Seok Kim (Korea) |
14:10-14:30 | Management of advanced liver disease in elderly patient | Ryosuke Tateishi (Japan) |
Nov. 30(Sat) |
Management of Advanced Liver Diseases | Convention Hall C (4F) |
Chair(s) | Jin Mo Yang (Korea), Naomi Khaing Than Hlaing (Myanmar) | |
14:30-14:50 | Stem cell therapy for cirrhosis | Soon Koo Baik (Korea) |
14:50-15:10 | Recent trend of Liver transplantation | Dong Jin Joo (Korea) |
15:10-15:30 | Emerging therapy of Hepatocellular Carcinoma | Markus Peck (Austria) |
Nov. 30(Sat) |
Presidential Lecture | |
Chair(s) | Dong Soo Han (Korea) | |
14:00-14:40 | Management strategies to improve outcomes of patients with IBD | Joo Sung Kim (Korea) |
Nov. 30(Sat) |
Special Lecture | |
Chair(s) | Joo Sung Kim (Korea) | |
14:40-15:20 | Recent updates of biomarkers in colorectal cancer screening | Joseph J. Y. Sung (Hong Kong) |
Nov. 30(Sat) 14:00-15:30 |
Pancreaticobiliary therapeutic intervention (I) | Emerald Hall A (3F) |
Chair(s) | Myung-Hwan Kim (Korea), Jong Ho Moon (Korea), Hsiu-Po Wang (Taiwan) | |
14:00-14:20 | Biliary Intervention in patients with surgically altered anatomy - EUS-BD or enteroscopy - | Mitsuhiro Kida (Japan) |
14:20-14:40 | EUS guided pancreatic cyst drainage and alcohol ablation | Ji Young Bang (USA) |
14:40-15:00 | EUS-guided gallbladder drainage: technical review and future prospects | Takeshi Ogura (Japan) |
15:00-15:20 | EUS-guided radiofrequency and fiducial placement | Rungsun Rerknimitr (Thailand) |
15:20-15:30 | Discussion |
Nov. 30(Sat) 14:00-15:30 |
Holistic approach for management of obesity and metabolic syndrome: exercies, diet, life style modification, phamacologic tx | Emerald Hall B (3F) |
Chair(s) | Kyu Rae Lee (Korea), Yong-Jin Kim (Korea) | |
14:00-14:25 | Non-pharmacological approach: life style modification, exercise and diet | Byoung-Duck Han (Korea) |
14:25-14:50 | Psychologic issues and intervention | Mirihae Kim (Korea) |
14:50-15:15 | Pharmacological treatment: An up-to-date | Kyoung-Kon Kim (Korea) |
15:15-15:30 | Panel discussion |
Nov. 30(Sat) 14:00-15:30 |
Controversial issues for management of advanced rectal rectal cancer | Diamond Hall (3F) |
Chair(s) | Jonghoon Lee (Korea), Jun Won Um (Korea) | |
14:00-14:22 | Preoperative stenting for left-sided obstructive disease: Should it be reserved for high risk group alone? | Jae Jun Park (Korea) |
14:22-14:44 | Optimal use of rectal radiation therapy for potentially resectable metastatic disease | Ji Ho Nam (Korea) |
14:44-15:06 | Timing of curative surgery for metastatic disease: when should we consult to surgeon? | Jin Yong Shin (Korea) |
15:06-15:28 | Recent advance of preoperative/postoperative systemic therapy | Suk-young Lee (Korea) |
Nov. 30(Sat) |
Grand Ballroom A (Main 2F) | |
Chair(s) | Sam Ryong Jee (Korea), Kyung SiK Park (Korea) | |
14:00-14:10 | Metabolically Healthy Obesity and the Risk of Erosive Esophagitis: A Cohort Study | Tae Jun Kim (Korea) |
14:10-14:20 | Alterations of mucosal impedance values in the duodenum and antrum of patients with functional dyspepsia | Kil Ho Lee (Korea) |
14:20-14:30 | The predictive factors of favorable outcomes in biofeedback therapy in defecatory dysfunction and fecal incontinence patients: real world experience | Jihye Park (Korea) |
14:30-14:40 | Initial Experience And Clinical Outcomes Of Peroral Endoscopic Myotomy For The Treatment Of Esophageal Achalasia And Esophageal Motility Disorders | Kyoungwon Jung (Korea) |
14:40-14:50 | An altered composition of gut microbiota, organic acids, and the effect of probiotics in the guinea pig model of postoperative ileus | Seung Yong Shin (Korea) |
Nov. 30(Sat) 14:00-15:30 |
Advanced nursing in GI cancer | Skylark (Main 2F) |
Chair(s) | Chan-Guk Park (Korea), Jun Kyu Lee (Korea) | |
14:00-14:22 | Oncology emmergencies in GI cancer | Chung Eun Lee (Korea) |
14:22-14:44 | Pain and nursing of GI dancer patients on chemotherapy | Boyoung Byun (Korea) |
14:44-15:06 | Patient safety and nursing of GI cancer patient on chemotherapy | Geun Suk Lee (Korea) |
15:06-15:28 | Social and emotional health and nursing of GI cancer patients on chemotherapy | Eun Ju Park (Korea) |
Nov. 30(Sat) 16:00-17:30 |
Treating acute pancreatitis; what's next? | Convention Hall A (4F) |
Chair(s) | Yong-Tae Kim (Korea), Young Deok Cho (Korea) | |
16:00-16:22 | Etiology and diagnosis, severity classification | Jun Kyu Lee (Korea) |
16:22-16:44 | Optimal medical management | Rungsun Rerknimitr (Thailand) |
16:44-17:06 | Optimal Endoscopic management | Ji Young Bang (USA) |
17:06-17:28 | Surveillence | Se Woo Park (Korea) |
Nov. 30(Sat) |
Convention Hall B (4F) | |
Chair(s) | Geun Am Song (Korea), Hyun-Soo Kim (Korea) | |
16:00-16:10 | Incidence and risk factors of micronutrient deficiency in the patients with inflammatory bowel disease in Korea: folate, vitamin B12, 25-OH-vitamin D, ferritin | Yong Eun Park (Korea) |
16:10-16:20 | Treatment of Ulcerative Colitis with Tonsil-derived Mesenchymal Stem Cells (T-MSCs) via Regulation of Programmed Death-1/Programmed Death Ligand-1 (PD-1/PD-L1) | Eun Mi Song (Korea) |
16:20-16:30 | Metagenomic biomarker for upper gastrointestinal tract involvement in patients with Crohn's disease | Min Seob Kwak (Korea) |
16:30-16:40 | Changes of fecal calprotectin and related clinical factor in neonates | Ji Sook Park (Korea) |
16:40-16:50 | Mechanisms of TL1A promoting epithelial-mesenchymal transition in chronic colitis-associated intestinal fibrosis | Wenxiu Jia (China) |
Nov. 30(Sat) |
Convention Hall B (4F) | |
Chair(s) | Jeong-Sik Byeon (Korea), Dong Il Park (Korea) | |
16:50-17:00 | The Efficacy and Safety of Adalimumab for Patients with Moderately to Severely Active Ulcerative Colitis and Predictors of Response in Korea | Seung Yong Shin (Korea) |
17:00-17:10 | Differentially abundant bacterial taxa associated with progression of Crohn's disease: results from the IMPACT study | Soo-Kyung Park (Korea) |
17:10-17:20 | Novel candidate drug in anti-tumor necrosis factor refractory Crohns diseases: In silico study for drug repositioning | Sara Jeong (Korea) |
17:20-17:30 | Dysbiosis before fecal microbiota transplantation is a positive predictor for a favorable outcome in ulcerative colitis patients | Sowon Park (Korea) |
17:30-17:40 | Molecular Mapping for Dissecting Colorectal Cancer Heterogeneity by MALDI Imaging | Pey Yee Lee (Malaysia) |
Nov. 30(Sat) 16:00-17:30 |
Global trend of SOC based on Guideline | Convention Hall C (4F) |
Chair(s) | Henry LY Chan (Hong Kong), Kwan Sik Lee (Korea), Seung Kew Yoon (Korea) | |
16:00-16:15 | Hepatitis B | Hyung Joon Yim (Korea) |
16:15-16:30 | Hepatitis C | Sang Hoon Ahn (Korea) |
16:30-16:45 | NAFLD and NASH | Henry LY Chan (Hong Kong) |
16:45-17:00 | Alcoholic liver disease | Dong Joon Kim (Korea) |
17:00-17:15 | Autoimmune liver disease | |
17:15-17:30 | Hepatocellular carcinoma | Ji Hoon Kim (Korea) |
Nov. 30(Sat) 16:00-17:30 |
Pancreaticobiliary therapeutic intervention (II) | Emerald Hall A (3F) |
Chair(s) | Sung Koo Lee (Korea), Don Haeng Lee (Korea), Sundeep Lakhtakia (India) | |
16:00-16:25 | RFA for CBD cancer | Jae Hee Cho (Korea) |
16:25-16:50 | Stent in stent for perihilar cholangiocarcinoma | Tae Hoon Lee (Korea) |
16:50-17:15 | Endoscopic techniques for post-endoscopic biliary sphincterotomy bleeding | Sundeep Lakhtakia (India) |
17:15-17:30 | Discussion |
Nov. 30(Sat) 16:00-17:30 |
Endoscopic and surgical intervention for obesity | Emerald Hall B (3F) |
Chair(s) | Seungho Choi (Korea), Roman Turro Arau (Spain) | |
16:00-16:22 | History, indication and reimbursement issue | Sung IL Choi (Korea) |
16:22-16:44 | Preliminary results with the gastric endoscopic sleeve plication (GESP) | Roman Turro Arau (Spain) |
16:44-17:06 | Surgical management of obesity- Bariatric surgery to metabolic surgery | Yong-Jin Kim (Korea) |
Nov. 30(Sat) 16:00-17:30 |
Solving 10 most frequently asked questions from FGID patients in the clinic | Diamond Hall (3F) |
Chair(s) | Soo Teik Lee (Korea), Poong-Lyul Rhee (Korea) | |
16:00-16:22 | Gastroesophageal reflux disease (GERD) | Jie-Hyun Kim (Korea) |
16:22-16:44 | Functional dyspepsia | Joong Goo Kwon (Korea) |
16:44-17:06 | Irritable bowel syndrome | Jeong Hwan Kim (Korea) |
17:06-17:28 | Chronic constipation | Jeong Eun Shin (Korea) |
Nov. 30(Sat) |
Grand Ballroom A (Main 2F) | |
Chair(s) | Moo-In Park (Korea), Hee Seok Moon (Korea) | |
16:00-16:10 | Clinical characteristics in young-age onset colorectal cancer | Subum Park (Korea) |
16:10-16:20 | Tolerability of adjuvant chemotherapy with TS-1 or XELOX regimen in elderly patients with stage II or III gastric cancer after D2 gastrectomy | Min Ji Cho (Korea) |
16:20-16:30 | Acute cardiac toxicity in concurrent chemoradiotherapy for oesophageal cancer | Theingi Htwe (Myanmar) |
16:30-16:40 | Hepatoid Adenocarcinoma Of Gastrointestinal Tract: Experience Of 23 Cases At A Single Tertiary-Care Oncology Centre | Munita Bal (India) |
16:40-16:50 | Optimal adjuvant therapy in patients with locally advanced pancreatic cancer who have received preoperative FOLFIRINOX | Min Kyu Kim (Korea) |
16:50-17:00 | Predictive factors for technical/clinical success of colorectal stenting in malignant colorectal obstruction | Ki-Hyun Kim (Korea) |